BEAUTY HEALTH CO/THE (SKIN) Forecast, Price Target & Analyst Ratings

NASDAQ:SKIN • US88331L1089

Current stock price

0.9127 USD
+0.01 (+1.52%)
At close:
0.9531 USD
+0.04 (+4.43%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BEAUTY HEALTH CO/THE (SKIN).

Forecast Snapshot

Consensus Price Target

Price Target
$1.73
+ 89.06% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 7, 2026
Period
Q1 / 2026
EPS Estimate
-$0.08
Revenue Estimate
67.777M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
51.43%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$1.73
Upside
+ 89.06%
From current price of $0.91 to mean target of $1.73, Based on 14 analyst forecasts
Low
$1.31
Median
$1.53
High
$2.63

Price Target Revisions

1 Month
-13.61%
3 Months
-12.50%

Price Target Summary

14 Wall Street analysts provided a forecast for the next 12 months for SKIN. The average price target is 1.73 USD. This implies a price increase of 89.06% is expected in the next year compared to the current price of 0.9127.
The average price target has been revised downward by 12.5% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

SKIN Current Analyst RatingSKIN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

SKIN Historical Analyst RatingsSKIN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
51.43%
SKIN was analyzed by 14 analysts. The buy percentage consensus is at 51. So analysts seem to be rather neutral about SKIN.
In the previous month the buy percentage consensus was at a similar level.
SKIN was analyzed by 14 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-16TD CowenMaintains Hold -> Hold
2026-03-13Canaccord GenuityMaintains Hold -> Hold
2026-01-21TD CowenMaintains Hold -> Hold
2025-09-22TD CowenMaintains Hold -> Hold
2025-09-19Roth CapitalInitiate Buy
2025-05-05Canaccord GenuityMaintains Hold -> Hold
2025-03-13Canaccord GenuityMaintains Hold -> Hold
2024-11-13Canaccord GenuityMaintains Hold -> Hold
2024-08-12Canaccord GenuityMaintains Hold -> Hold
2024-08-09Piper SandlerReiterate Underweight -> Underweight
2024-07-26StifelMaintains Hold -> Hold
2024-07-11Piper SandlerMaintains Underweight -> Underweight
2024-05-13TD CowenMaintains Hold -> Hold
2024-05-13DA DavidsonMaintains Buy -> Buy
2024-05-10Piper SandlerMaintains Underweight -> Underweight
2024-03-15DA DavidsonMaintains Buy -> Buy
2024-03-14Canaccord GenuityMaintains Hold -> Hold
2024-03-13TD CowenMaintains Market Perform -> Market Perform
2024-03-13StifelReiterate Hold -> Hold
2024-03-13Piper SandlerReiterate Underweight -> Underweight
2024-02-29Canaccord GenuityMaintains Hold -> Hold
2023-11-15JefferiesDowngrade Buy -> Hold
2023-11-14TD CowenDowngrade Outperform -> Market Perform
2023-11-14William BlairDowngrade Outperform -> Market Perform
2023-11-14BenchmarkDowngrade Buy -> Hold

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 7, 2026
Period
Q1 / 2026
EPS Estimate
-$0.08
Revenue Estimate
67.777M
Revenue Q2Q
-2.62%
EPS Q2Q
1.65%
Number of Analysts
10

Next Earnings Revisions

Revenue (1 Month)
-1.18%
Revenue (3 Months)
-5.37%
EPS (1 Month)
-10.20%
EPS (3 Months)
-59.61%

Next Earnings Summary

SKIN is expected to report earnings on 5/7/2026. The consensus EPS estimate for the next earnings is -0.08 USD and the consensus revenue estimate is 67.78M USD.
The next earnings revenue estimate has been revised downward by 5.37% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2032

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2032
Revenue
YoY % growth
SKIN revenue by date.SKIN revenue by date.
397.991M
8.77%		334.294M
-16.00%		300.79M
-10.02%		303.45M
0.88%		317.42M
4.60%		328.37M
3.45%		512.04M
EBITDA
YoY % growth
SKIN ebitda by date.SKIN ebitda by date.
-60.778M
-912.54%		-10.297M
83.06%		7.233M
170.24%		39.269M
442.91%		42.584M
8.44%		45.05M
5.79%		N/A
EBIT
YoY % growth
SKIN ebit by date.SKIN ebit by date.
-93.017M
-387.00%		-39.774M
57.24%		-13.603M
65.80%		-7.638M
43.85%		-4.423M
42.09%		-3.06M
30.82%		N/A
Operating Margin
SKIN operating margin by date.SKIN operating margin by date.
-23.37%-11.90%-4.52%-2.52%-1.39%-0.93%N/A
EPS
YoY % growth
SKIN eps by date.SKIN eps by date.
0.16
-51.52%		-0.18
-211.88%		-0.20
-11.73%		-0.14
28.60%		-0.13
8.57%		-0.04
66.15%		N/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.08
1.65%		-0.03
-202.00%		-0.05
43.33%		-0.02
68.84%		-0.06
28.70%		-0.04
-16.67%		-0.06
-20.00%		-0.04
-90.94%
Revenue
Q2Q % growth		67.777M
-2.62%		78.3M
0.13%		72.85M
3.11%		84.674M
2.76%		70.023M
3.31%		80.427M
2.72%		74.919M
2.84%		88.128M
4.08%
EBITDA
Q2Q % growth		4.72M
167.55%		11.467M
71.97%		9.835M
-6.11%		13.99M
-50.39%		7.548M
59.92%		11.577M
0.96%		11.577M
17.71%		14.076M
0.61%
EBIT
Q2Q % growth		-6.996M
41.81%		-109.65K
95.94%		-2.746M
56.01%		1.403M
-80.94%		-9.282M
-32.68%		-4.794M
-4,272.09%		-5.406M
-96.89%		-6.63M
-572.56%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

SKIN Yearly Revenue VS EstimatesSKIN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2032 100M 200M 300M 400M 500M
SKIN Yearly EPS VS EstimatesSKIN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 -0.5 -1 -1.5 -2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
21.17%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
2.77%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
55.75%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

BEAUTY HEALTH CO/THE / SKIN Forecast FAQ

What do analysts expect the price target to be for BEAUTY HEALTH CO/THE (SKIN)?

14 analysts have analysed SKIN and the average price target is 1.73 USD. This implies a price increase of 89.06% is expected in the next year compared to the current price of 0.9127.

When does BEAUTY HEALTH CO/THE (SKIN) report earnings?

BEAUTY HEALTH CO/THE (SKIN) will report earnings on 2026-05-07, after the market close.

What are the consensus estimates for SKIN stock next earnings?

The consensus EPS estimate for the next earnings of BEAUTY HEALTH CO/THE (SKIN) is -0.08 USD and the consensus revenue estimate is 67.78M USD.

What is the number of analysts for SKIN stock?

The number of analysts covering BEAUTY HEALTH CO/THE (SKIN) is 14.